Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've looked into tirzepatide and now you're wondering whether a blood test is part of the process. The short answer: a formal blood test isn't always required before treatment begins, but your prescriber will assess your health in detail, and some baseline blood results can genuinely shape what happens next. These are prescription-only medicines, so clinical judgement, not a checkbox, determines what's right for you. Tirzepatide is the active ingredient in Mounjaro, licensed in the UK for weight management in adults whose BMI meets the criteria, alongside a reduced-calorie diet and increased physical activity. Before anything else, a qualified clinician reviews your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've filled in your health questionnaire, uploaded your photo ID, and completed the live weight check. Your answers land on a prescriber's desk, a real clinician, not an automated filter. What they're doing at that point is building a clinical picture. Blood test results, if you have them, slot into that picture as useful evidence. They're not always mandatory, but they can matter a great deal.
The conditions most likely to make a prescriber reach for your blood results are type 2 diabetes (HbA1c and fasting glucose tell the story of blood-sugar control), kidney function (tirzepatide is used with caution when renal function is significantly impaired), thyroid status, and lipid panels for cardiovascular risk. If you've recently had a set of bloods through your GP, sharing those results at consultation means the prescriber isn't working in the dark. The tirzepatide overview on this site explains the broader eligibility picture in more depth.
None of this means you must arrive with a folder of lab reports. Many people starting tirzepatide for straightforward weight management (no diabetes, no thyroid condition, no kidney concerns flagged) are assessed on symptoms, BMI, medical history and medicines alone. The prescriber decides what additional information they need. That's the point of clinical review rather than an online quiz.
This question comes up more than you might expect. Someone asks whether tirzepatide will appear on a routine NHS blood test, a workplace panel, or a drugs screen. The answer, in practical terms, is no. A full blood count, liver function panel, HbA1c, or standard urine drug screen is not designed to identify tirzepatide. The molecule has a specific peptide structure that wouldn't register on any of those tests.
Detecting tirzepatide analytically requires a targeted immunoassay or LC-MS/MS method developed specifically for the compound. These are research or specialist clinical tools, not the panels a GP practice or occupational health provider runs. If you're concerned about a specific screening context, the tirzepatide and drug testing page works through the scenarios in more detail. For most people reading this, the practical answer is simply: standard blood tests won't flag tirzepatide.
It's also worth knowing that if you're monitoring your own health during treatment, tirzepatide won't interfere with the accuracy of common blood tests. HbA1c results, for instance, are genuinely useful progress markers for people with diabetes on tirzepatide, and the medicine doesn't distort the assay. The question of whether Mounjaro shows up on a blood test is answered with that same clarity elsewhere on this site.
Starting tirzepatide isn't a one-and-done event. For people with type 2 diabetes, HbA1c monitoring every three months or so remains clinically sensible, partly because the medicine improves blood-sugar control, which is welcome, but also because doses of other diabetes medicines like sulphonylureas may need adjusting as glucose levels fall. The risk of hypoglycaemia in that combination is real, and it's a conversation to have with your prescriber before it becomes a surprise. The NHS medicines information for tirzepatide covers this interaction clearly.
Kidney function tests are worth repeating if you experience significant vomiting or diarrhoea during dose titration, since dehydration can place temporary strain on the kidneys. Liver enzymes occasionally shift during substantial weight loss of any kind; this is usually benign but worth noting if you have a history of liver disease.
Cholesterol and triglyceride panels often improve on tirzepatide as weight falls and metabolic health shifts, the SURMOUNT-1 trial, published in the New England Journal of Medicine, documented meaningful improvements in cardiometabolic markers alongside weight reduction. That doesn't mean you need monthly bloods; it means periodic checks give a fuller picture of how well treatment is working beyond the number on the scales.
Our clinical team reviews your health at every repeat order, not just at the start. There's more on how that process works (and what it covers) on the blood tests and Mounjaro page. If you're curious about the broader cost of treatment and what a single transparent price actually covers, the Mounjaro price comparison page sets that out honestly. And if you're ready to have a prescriber look at your specific situation, starting your free consultation is the natural next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.